Dissemin is shutting down on January 1st, 2025

Published in

Springer Nature [academic journals on nature.com], Pediatric Research, (18), p. 322A-322A

DOI: 10.1203/00006450-198404001-01374

Links

Tools

Export citation

Search in Google Scholar

Evaluation of Dexamethasone in the Prevention of Severe Bronchopulmonary Dysplasia

Journal article published in 1984 by Keith Barrington, Neil Finer, Barrington Kj ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

In view of previous studies suggesting that steroids may be of benefit in reducing the severity of bronchopulmonary dysplasia (BPD), we administered a brief, rapidly tapered course of dexamethasone (.5 mg/kg/day for 3 days followed by .25 mg/kg for 2 days, and then a single dose of .25 mg/kg 48 hr later) to 8 neonates (Birth Weight 580 - 1490 gm, Gest 26 - 29 wk) with evidence of early BPD beginning at 17 - 24 days of age; 4 infants received 2 separate courses. All infants were intubated requiring IMV or required an FIO2 >.4 having been previously ventilated. There was a significant improvement in alveolar-arterial oxygen gradient (A-a)DO2 seen over the 7 day period beginning within 6 hours of starting therapy (F4-55 = 2.84, p <.05).